Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes

被引:1
|
作者
Tohi, Yoichiro [1 ]
Kato, Takuma [1 ]
Matsuda, Iori [1 ]
Honda, Tomoko [1 ]
Osaki, Yu [1 ]
Naito, Hirohito [1 ]
Matsuoka, Yuki [1 ]
Okazoe, Homare [1 ]
Taoka, Rikiya [1 ]
Ueda, Nobufumi [1 ]
Sugimoto, Mikio [1 ]
机构
[1] Kagawa Univ, Fac Med, Dept Urol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan
关键词
active surveillance; quality of life; patient-reported outcomes; prostate cancer; MEN; CRITERIA; THERAPY; PRIAS;
D O I
10.1093/jjco/hyac201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During active surveillance, the health-related quality of life of younger Japanese patients was maintained over time, and the surveillance period was shorter in younger patients compared with older patients. Objective this study aimed to evaluate the active surveillance continuation period, treatment intervention rate and health-related quality of life in younger patients. Methods we prospectively conducted a health-related quality of life survey of patients enrolled in the Prostate Cancer Research International: Active Surveillance-JAPAN study at Kagawa University between January 2010 and December 2020. Health-related quality of life was assessed by mail using a validated Japanese version of the Short-Form 8 Health Survey and Expanded Prostate Cancer Index at active surveillance enrolment and annually thereafter until discontinuation of active surveillance. We divided the patients into two groups, younger (aged <65 years) and older (aged >= 65 years), and compared the two groups. Results of the 84 patients, 22 were in the younger group. The active surveillance continuation period was shorter in the younger group than in the older group. The 3-year treatment intervention rate was higher in the younger group than in the older group. The majority of the reasons for definitive treatment were related to the protocol, which was similar in both groups (80 versus 76%). The sexual summary scores at active surveillance enrolment were higher in the younger group than in the older group. During active surveillance, the younger group and the older group showed no deterioration in all health-related quality of life scores compared with the scores at the enrolment of active surveillance. Conclusions patient-reported health-related quality of life survey indicated that the health-related quality of life of younger Japanese patients was maintained over time during active surveillance, similar to that of older patients.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 50 条
  • [21] The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it
    Smith, Tenbroeck G.
    Castro, Kathleen M.
    Troeschel, Alyssa N.
    Arora, Neeraj K.
    Lipscomb, Joseph
    Jones, Shelton M.
    Treiman, Katherine A.
    Hobbs, Connie
    McCabe, Ryan M.
    Clauser, Steven B.
    CANCER, 2016, 122 (03) : 344 - 351
  • [22] Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer
    Cavanna, Luigi
    Citterio, Chiara
    Orlandi, Elena
    PATIENT-RELATED OUTCOME MEASURES, 2020, 11 : 49 - 66
  • [23] Including Patient-Reported Outcomes and Patient-Reported Resource-Use Questionnaires in Studies
    Bresnahan, Brian W.
    Rundell, Sean D.
    ACADEMIC RADIOLOGY, 2014, 21 (09) : 1129 - 1137
  • [24] Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients
    Smith, Angela B.
    Samuel, Cleo A.
    McCabe, Sean D.
    Deal, Allison
    Jonsson, Mattias
    Mueller, Dana E.
    Mahbooba, Zahra M.
    Bennett, Antonia, V
    Chung, Arlene E.
    Nielsen, Matthew E.
    Tan, Hung-Jui
    Wallen, Eric
    Pruthi, Raj
    Wang, Andrew
    Basch, Ethan
    Reeve, Bryce B.
    Chen, Ronald C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (01) : 77.e1 - 77.e8
  • [25] Patient-reported Outcomes in Randomised Controlled Trials of Prostate Cancer: Methodological Quality and Impact on Clinical Decision Making
    Efficace, Fabio
    Feuerstein, Michael
    Fayers, Peter
    Cafaro, Valentina
    Eastham, James
    Pusic, Andrea
    Blazeby, Jane
    EUROPEAN UROLOGY, 2014, 66 (03) : 416 - 427
  • [26] Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials
    Tombal, Bertrand F.
    Freedland, Stephen J.
    Armstrong, Andrew J.
    Beer, Tomasz M.
    Stenzl, Arnulf
    Sternberg, Cora N.
    Hussain, Maha
    Ganguli, Arijit
    Ramaswamy, Krishnan
    Bhadauria, Hemant
    Ivanescu, Cristina
    Turnbull, James
    Holmstrom, Stefan
    Saad, Fred
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (02) : 288 - 295
  • [27] Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection
    Merrick, Gregory S.
    Tennant, Ava
    Fiano, Ryan
    Bennett, Abbey
    Anderson, Richard
    Galbreath, Robert
    Butler, Wayne M.
    Adamovich, Edward
    WORLD JOURNAL OF UROLOGY, 2020, 38 (02) : 361 - 369
  • [28] Patient-reported outcomes and localized prostate cancer management
    Mercieca-Bebber, Rebecca
    Stockler, Martin R.
    NATURE REVIEWS UROLOGY, 2020, 17 (05) : 257 - 258
  • [29] A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer
    Helou, Joelle
    Morton, Gerard
    Kiss, Alex
    Mittmann, Nicole
    Ravi, Ananth
    Chung, Hans
    Davidson, Melanie
    Cheung, Patrick
    Bezjak, Andrea
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2022, 171 : 164 - 172
  • [30] Clinical Outcome Assessment in Cancer Rehabilitation and the Central Role of Patient-Reported Outcomes
    Lehmann, Jens
    Rothmund, Maria
    Riedl, David
    Rumpold, Gerhard
    Grote, Vincent
    Fischer, Michael J.
    Holzner, Bernhard
    CANCERS, 2022, 14 (01)